SENEXON-S description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

SENEXON-S

NCS HealthCare of KY, Inc dba Vangard Labs

Senexon-S Tablets


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Docusate sodium 50 mg

Sennosides 8.6 mg

Stool Softener

Stimulant Laxative 

• relieves occasional constipation

• generally produces bowel movement in 6 - 12 hours 

Do not use  • if you are taking mineral oil     • for longer than one week    • when abdominal pain, nausea or vomiting are present

Ask a doctor before use if you have noticed a sudden change in bowel habits that lasts over two weeks

Ask a doctor or pharmacist before use if you are taking any other drug. Take this product two or more hours before or after other drugs. Laxatives may affect how other drugs work.

Stop use and ask a doctor if   • you have rectal bleeding  • you fail to have a bowel movement after use of this product. 

These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

• take preferably at bedtime or as directed by a doctor

• if you do not have a comforable bowel movement by the second day, increase dose by one tablet (do not exceed maximum dosage)

age starting dosage maximum dosage
adults and children 12 years and older 2 tablets once daily 4 tablets twice daily
children 5 to under 12 years 1 tablet once daily 2 tablets twice daily
children 2 to under 6 years 1/2 tablet once daily 1 tablet twice daily
children under 2 years ask a doctor ask a doctor

• each tablet contains: calcium 20 mg, sodium 6 mg (LOW SODIUM)

• store at 20º - 25ºC (68º - 77ºF) 

carnauba wax, colloidal silicon dioxide, croscarmellose sodium, D&C yellow #10 aluminum lake, dibasic calcium phosphate dihydrate, FD&C yellow #6 aluminum lake, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, sodium benzoate, stearic acid, titanium dioxide

1-800-645-2158

 Dispense contents with a child-resistant closure in a tight, light-resistant container as defined in the USP.

192R

Distributed by: Rugby Laboratories

31778 Enterprise Drive, Livonia, MI 48150

R-14  Rev. 03/13

Principal Display Panel

SENEXON-S

SENEXON-S

docusate sodium-sennosides tablet TABLET, COATED

Product Information

Product Type Human otc drug label Item Code (Source) NDC:0615-7773(NDC:0536-4086)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
SENNOSIDES A AND B SENNOSIDES A AND B 8.6 mg
DOCUSATE SODIUM DOCUSATE 50 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE
HYPROMELLOSES
MAGNESIUM STEARATE
cellulose, microcrystalline
carnauba wax
SILICON DIOXIDE
D&C YELLOW NO. 10
FD&C YELLOW NO. 6
POLYETHYLENE GLYCOLS
SODIUM BENZOATE
STEARIC ACID
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
ORANGE 9 mm TCL081 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0615-7773-31 31 in 1 BLISTER PACK
2 NDC:0615-7773-39 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part334 2006-02-09


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.